2,659
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Surface-engineered smart nanocarrier-based inhalation formulations for targeted lung cancer chemotherapy: a review of current practices

, &
Pages 1995-2010 | Received 08 Feb 2021, Accepted 22 Jun 2021, Published online: 27 Sep 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jing Wang, Yan Zhang, GuangPeng Zhang, Li Xiang, HaoWen Pang, Kang Xiong, Yun Lu, JianMei Li, Jie Dai, Sheng Lin & ShaoZhi Fu. (2022) Radiotherapy-induced enrichment of EGF-modified doxorubicin nanoparticles enhances the therapeutic outcome of lung cancer. Drug Delivery 29:1, pages 588-599.
Read now

Articles from other publishers (10)

Shuiying Zhang, Rui Li, Tong Jiang, Yihan Gao, Kai Zhong, Hong Cheng, Xin Chen & Shiying Li. (2024) Inhalable nanomedicine for lung cancer treatment. Smart Materials in Medicine 5:2, pages 261-280.
Crossref
Gayathri R. Ediriweera, Neville J. Butcher, Ashok Kothapalli, Jiacheng Zhao, Joanne T. Blanchfield, Christopher N. Subasic, James L. Grace, Changkui Fu, Xiao Tan, John F. Quinn, David B. Ascher, Michael R. Whittaker, Andrew K. Whittaker & Lisa M. Kaminskas. (2024) Lipid sulfoxide polymers as potential inhalable drug delivery platforms with differential albumin binding affinity. Biomaterials Science 12:11, pages 2978-2992.
Crossref
Hussein M. Eid, Toqa H. Turkia, Adel A. Ali & Heba M. Aboud. (2024) A Novel Chitosan-coated Leciplex Loaded with Ambrisentan as a Possible Pulmonary Nanosystem: Optimization, Characterization, and Pharmacokinetics Assessments. Journal of Pharmaceutical Sciences.
Crossref
Giti Esmail Nia, Elahe Nikpayam, Molood Farrokhi, Azam Bolhassani & Ralph Meuwissen. (2024) Advances in cell-based delivery of oncolytic viruses as therapy for lung cancer. Molecular Therapy: Oncology 32:1, pages 200788.
Crossref
Mohit Kumar, Ayah R. Hilles, Samah Hamed Almurisi, Amit Bhatia & Syed Mahmood. (2023) Micro and nano-carriers-based pulmonary drug delivery system: Their current updates, challenges, and limitations – A review. JCIS Open 12, pages 100095.
Crossref
Jaroslaw Smieja. (2023) Mathematical Modeling Support for Lung Cancer Therapy—A Short Review. International Journal of Molecular Sciences 24:19, pages 14516.
Crossref
Yaoguo Lang, Xianglong Kong, Benkun Liu, Xiangyuan Jin, Lantao Chen & Shidong Xu. (2023) Effects of the microRNA-99a-5p/VLDLR axis in lung cancer cell sensitivity to chemotherapy and its mechanism. Brazilian Journal of Pharmaceutical Sciences 59.
Crossref
Mohammad Habeeb, Tasneem Abdul Kareem, Kolluru Lakshmi Deepthi, Vidyarani Sujitkumar Khot, You Huay Woon & Sarita Suryabhan Pawar. (2022) Nanomedicine for targeting the lung cancer cells by interpreting the signaling pathways. Journal of Drug Delivery Science and Technology 77, pages 103865.
Crossref
Siqi Ma, Zhaoqing Cong, Jiaxing Wei, Weiya Chen, Di Ge, Feifei Yang & Yonghong Liao. (2022) Pulmonary delivery of size-transformable nanoparticles improves tumor accumulation and penetration for chemo-sonodynamic combination therapy. Journal of Controlled Release 350, pages 132-145.
Crossref
Juan Zhao, Ling Wang, Haiwei Zhang, Bin Liao & Yongsheng Li. (2022) Progress of Research in In Situ Smart Hydrogels for Local Antitumor Therapy: A Review. Pharmaceutics 14:10, pages 2028.
Crossref